XML 63 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue Disaggregated Revenue by Product Line (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 553,311 $ 597,857 $ 1,671,270 $ 1,701,983
Disaggregation of Revenue [Table Text Block]     The following table represents our revenues disaggregated by product line (in thousands):
Three months ended
September 30,		Nine months ended
September 30,
Product line2023202220232022
Consumables242,010 251,572 715,108 732,756 
Infusion Systems148,981 161,555 463,836 448,426 
Vital Care162,320 184,730 492,326 520,801 
Total Revenues$553,311 $597,857 $1,671,270 $1,701,983 

For the three and nine months ended September 30, 2023, net sales to Medline made up approximately 18% and 16% of total revenues, respectively. For the three and nine months ended September 30, 2022, net sales to Medline made up approximately 16% and 15% of total revenues, respectively.

The following table represents our revenues disaggregated by geography (in thousands):
Three months ended
September 30,		Nine months ended
September 30,
Geography2023202220232022
United States$355,984 $376,691 $1,063,037 $1,088,348 
Europe, the Middle East and Africa88,014 101,869 276,994 275,488 
APAC59,064 66,569 177,719 191,847 
Other Foreign50,249 52,728 153,520 146,300 
Total Revenues$553,311 $597,857 $1,671,270 $1,701,983 
  
Infusion Consumables [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 242,010 251,572 $ 715,108 732,756
Infusion Systems [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 148,981 161,555 463,836 448,426
Vital Care        
Disaggregation of Revenue [Line Items]        
Revenues $ 162,320 $ 184,730 $ 492,326 $ 520,801